title: [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
abstract: Haemolytic disease of the fetus and newborn/HDFN/is a condition in which the lifespan of the fetal or newborn infants red cells is shortened by the action of maternal antibodies against antigens present on the infants red cells. The most common routes of maternal sensitization are via blood transfusion or fetomaternal hemorrhage. With the institution of antenatal Rhesus (Rh) D immunoglobulin prophylaxis, the frequency of maternal alloimmunization in Rh D-negative women has decreased significantly. The prevention and treatment of Rh D alloimmunization is a true success story in obstetrics. This article present the reasons for the persistence of the anti-D alloimmunization, protocol for the prevention and diagnosis of HDFN, immunohematological management of all pregnant women, critical titre, protocol and timing in alloimmunized pregnant women.
authors.forename: R
authors.initials: R
authors.lastname: Kulinska
mesh_terms: D004899:Erythroblastosis, Fetal / Q000097:blood* / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007231:Infant, Newborn; D007518:Isoantibodies / Q000097:blood; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000097:blood; D018029:Rho(D) Immune Globulin
chemical_list: D007518:Isoantibodies; C061961:RHO(D) antibody; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin